title: A very rare case of encephalopathy in a patient with end-stage renal disease: contrast agent, ioversol.
abstract: Contrast agents are associated with a number of adverse effects, including central nervous system effects. These agents are primarily filtered and excreted by the kidney. Contrast-associated encephalopathy is a rare complication. We report the case of a 55-year-old male on chronic hemodialysis who developed confusion and agitation after receiving ioversol during abdominal angiography. Although hemodialysis was performed his healing took 15 days. Patients with end-stage renal disease may be at an increased risk of adverse effects of contrast agents.
authors.affiliation: Department of Nephrology, Baskent University Faculty of Medicine, Adana Teaching and Medical Research Center, Adana, Turkey. rusancak@hotmail.com
authors.forename: Ruya
authors.initials: R
authors.lastname: Ozelsancak
authors.forename: Ertugrul
authors.initials: E
authors.lastname: Erken
authors.forename: Ismail
authors.initials: I
authors.lastname: Yildiz
authors.forename: Semih
authors.initials: S
authors.lastname: Giray
authors.forename: Tulin
authors.initials: T
authors.lastname: Yildirim
authors.forename: Hasan
authors.initials: H
authors.lastname: Micozkadioglu
mesh_terms: D003287:Contrast Media / Q000009:adverse effects*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D008875:Middle Aged; D020258:Neurotoxicity Syndromes / Q000209:etiology*; D014283:Triiodobenzoic Acids / Q000009:adverse effects*
chemical_list: D003287:Contrast Media; D014283:Triiodobenzoic Acids; C054871:ioversol